X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14814) 14814
Publication (1166) 1166
Book Review (66) 66
Book Chapter (64) 64
Dissertation (52) 52
Conference Proceeding (41) 41
Newsletter (15) 15
Government Document (7) 7
Book / eBook (5) 5
Magazine Article (5) 5
Web Resource (5) 5
Data Set (3) 3
Streaming Video (2) 2
Journal / eJournal (1) 1
Newspaper Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10598) 10598
camptothecin - analogs & derivatives (8423) 8423
oncology (5316) 5316
index medicus (5102) 5102
camptothecin - administration & dosage (4947) 4947
camptothecin (4861) 4861
female (4810) 4810
male (4474) 4474
camptothecin - pharmacology (3669) 3669
antineoplastic combined chemotherapy protocols - therapeutic use (3613) 3613
middle aged (3528) 3528
animals (3353) 3353
aged (3314) 3314
irinotecan (3175) 3175
cancer (2896) 2896
chemotherapy (2777) 2777
adult (2721) 2721
camptothecin - therapeutic use (2358) 2358
pharmacology & pharmacy (2224) 2224
colorectal neoplasms - drug therapy (2134) 2134
mice (1925) 1925
treatment outcome (1882) 1882
fluorouracil - administration & dosage (1775) 1775
camptothecin - adverse effects (1757) 1757
cell line, tumor (1660) 1660
apoptosis (1417) 1417
colorectal neoplasms - pathology (1394) 1394
biochemistry & molecular biology (1362) 1362
colorectal cancer (1342) 1342
antineoplastic combined chemotherapy protocols - adverse effects (1339) 1339
topoisomerase i inhibitors (1332) 1332
antineoplastic agents - pharmacology (1309) 1309
leucovorin - administration & dosage (1205) 1205
cpt-11 (1174) 1174
camptothecin - pharmacokinetics (1172) 1172
organoplatinum compounds - administration & dosage (1141) 1141
antineoplastic agents, phytogenic - pharmacology (1103) 1103
drug administration schedule (1092) 1092
dose-response relationship, drug (1079) 1079
antineoplastic agents, phytogenic - administration & dosage (1075) 1075
antineoplastic combined chemotherapy protocols - administration & dosage (1060) 1060
apoptosis - drug effects (1055) 1055
camptothecin - chemistry (1048) 1048
fluorouracil (990) 990
antineoplastic agents - therapeutic use (989) 989
dna topoisomerases, type i - metabolism (942) 942
antineoplastic agents, phytogenic - therapeutic use (918) 918
lung neoplasms - drug therapy (912) 912
analysis (904) 904
oxaliplatin (885) 885
research (885) 885
tumor cells, cultured (858) 858
aged, 80 and over (854) 854
topotecan (841) 841
neoplasms - drug therapy (827) 827
disease-free survival (818) 818
care and treatment (816) 816
dna damage (811) 811
cisplatin - administration & dosage (801) 801
topoisomerase-i (797) 797
survival rate (779) 779
bevacizumab (776) 776
adenocarcinoma - drug therapy (775) 775
tumors (771) 771
therapy (767) 767
drugs (762) 762
antineoplastic agents - administration & dosage (756) 756
leucovorin (755) 755
expression (753) 753
enzyme inhibitors - pharmacology (748) 748
antitumor-activity (743) 743
deoxycytidine - analogs & derivatives (738) 738
cisplatin (733) 733
fluorouracil - therapeutic use (728) 728
cell survival - drug effects (724) 724
neoplasm staging (722) 722
liver neoplasms - secondary (721) 721
antineoplastic agents (720) 720
pharmacokinetics (718) 718
cell biology (705) 705
metastasis (694) 694
neoplasm metastasis (681) 681
chemistry, medicinal (677) 677
phase-ii (674) 674
chemistry, multidisciplinary (671) 671
medicine & public health (663) 663
cells (661) 661
5-fluorouracil (654) 654
dna (652) 652
trial (651) 651
article (629) 629
retrospective studies (622) 622
carcinoma (618) 618
liver neoplasms - drug therapy (614) 614
mice, nude (614) 614
cytotoxicity (613) 613
rats (613) 613
combination (609) 609
antimitotic agents (608) 608
drug delivery systems (605) 605
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13684) 13684
Japanese (772) 772
Chinese (271) 271
French (112) 112
German (50) 50
Russian (22) 22
Hungarian (14) 14
Korean (11) 11
Italian (10) 10
Spanish (10) 10
Czech (4) 4
Dutch (3) 3
Lithuanian (3) 3
Polish (3) 3
Swedish (2) 2
Danish (1) 1
Norwegian (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 14, pp. 2311 - 2319
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2017, Volume 2017, Issue 8, pp. CD004064 - CD004064
Journal Article
ACS Nano, ISSN 1936-0851, 09/2017, Volume 11, Issue 9, pp. 8838 - 8848
Journal Article
Investigational New Drugs, ISSN 0167-6997, 8/2013, Volume 31, Issue 4, pp. 986 - 1000
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 19, pp. 3843 - 3854
BACKGROUND Sacituzumab govitecan (IMMU‐132), an antitrophoblastic cell‐surface antigen (anti‐Trop‐2) humanized antibody‐SN‐38 conjugate, had encouraging... 
clinical trial | trophoblastic cell‐surface antigen (Trop‐2) | epithelial cancers | antibody‐drug conjugate | IMMU‐132 (sacituzumab govitecan) | SN‐38 | trophoblastic cell-surface antigen (Trop-2) | SN-38 | antibody-drug conjugate | IMMU-132 (sacituzumab govitecan) | METABOLITES | SOLID TUMORS | ETIRINOTECAN PEGOL NKTR-102 | CLINICAL PHARMACOKINETICS | BREAST-CANCER | EZN-2208 | ONCOLOGY | COLORECTAL-CANCER | THERAPEUTIC TARGET | IRINOTECAN | trophoblastic cellsurface antigen (Trop-2) | Neoplasms - metabolism | Humans | Middle Aged | Half-Life | Immunoconjugates - pharmacokinetics | Male | Response Evaluation Criteria in Solid Tumors | Immunoconjugates - administration & dosage | Glucuronosyltransferase - genetics | Antineoplastic Agents, Phytogenic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Time Factors | Antibodies, Monoclonal, Humanized - pharmacokinetics | Camptothecin - blood | Aged, 80 and over | Antigens, Neoplasm - metabolism | Adult | Camptothecin - administration & dosage | Female | Neutropenia - chemically induced | Antineoplastic Agents, Phytogenic - pharmacokinetics | Antineoplastic Agents, Phytogenic - adverse effects | Camptothecin - analogs & derivatives | Immunoconjugates - adverse effects | Camptothecin - pharmacokinetics | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Cell Adhesion Molecules - metabolism | Neoplasms - drug therapy | Irinotecan | Aged | Immunoglobulin G - metabolism | Usage | Care and treatment | Safety and security measures | Analysis | Epithelial tumors | Pharmacokinetics | Antibody-drug conjugates | Camptothecin | Antigens | Toxicity | Immunoglobulin G | Radioactive half-life | Breast cancer | Pharmacology | Metastasis | Criteria | Patients | Cell surface | Metastases | Uridine | Safety | Solid tumors | Drug dosages | Cancer | Tumors | Half life | Neutropenia | Glucuronosyltransferase | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 02/2017, Volume 247, pp. 28 - 54
Journal Article